[Clinical evaluation of the TPN 12 (Sandoz) preparation in the treatment of mental disorders].
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000368:Aged; D004361:Drug Tolerance; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D008297:Male; D001523:Mental Disorders / Q000188:drug therapy*; D008875:Middle Aged; D009249:NADP / Q000008:administration & dosage*; D010640:Phenothiazines / Q000008:administration & dosage / Q000627:therapeutic use*; D010880:Piperidines / Q000008:administration & dosage / Q000627:therapeutic use; D013450:Sulfones / Q000008:administration & dosage / Q000627:therapeutic use; D014149:Tranquilizing Agents / Q000008:administration & dosage / Q000627:therapeutic use*
D010640:Phenothiazines; D010880:Piperidines; D013450:Sulfones; D014149:Tranquilizing Agents; D009249:NADP
Ocena kliniczna działania preparatu TPN 12 Sandoz w leczeniu zaburzeń psychicznych.